An economic evaluation of pre-dialysis stage of chronic kidney disease

Objective: to review clinical and economic studies on the pre-dialysis stage of chronic kidney disease (CKD) and the cost-effectiveness of medical interventions used to detect CKD and prevent its progression.Material and methods. Articles were collected from the bibliographic databases PubMed, Cochr...

Full description

Saved in:
Bibliographic Details
Main Authors: E. I. Rumiantseva, M. V. Avxentyeva
Format: Article
Language:Russian
Published: IRBIS LLC 2021-10-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/551
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850050217710190592
author E. I. Rumiantseva
M. V. Avxentyeva
author_facet E. I. Rumiantseva
M. V. Avxentyeva
author_sort E. I. Rumiantseva
collection DOAJ
description Objective: to review clinical and economic studies on the pre-dialysis stage of chronic kidney disease (CKD) and the cost-effectiveness of medical interventions used to detect CKD and prevent its progression.Material and methods. Articles were collected from the bibliographic databases PubMed, Cochrane Library and eLibrary for 2010–2020. Keywords for the search: ‘chronic kidney disease (CKD)’, ‘cost-effectiveness’, ‘economic evaluation’, ‘economic burden’, ‘cost’, ‘healthcare’. After the selection and elimination of the repeated articles, we reviewed 36 Russian and foreign studies on the economic burden of CKD and the clinical and economic effectiveness of various medical interventions of the CKD pre-dialysis stage.Results. We found 21 studies on the economic burden of CKD. A significant part of them (n=6) was performed in the United States.The methodology for assessing the economic burden varied significantly from study to study. Studies on medical interventions at the CKD predialysis stage can be divided into three groups: Group 1 (n=9) – studies on the clinical and economic effectiveness of screening programs; Group 2 (n=3) – studies on the clinical and economic effectiveness of nephroprotectors and other drugs that slow down the course of CKD; and Group 3 (n=3) – studies on the clinical and economic effectiveness of multidisciplinary care. We concluded on the clinical and economic feasibility of most interventions that were used to detect CKD and prevent its progression.Conclusion. We did not find any scientific data that could currently serve as a justification for the clinical and economic feasibility of CKD control programs in the Russian Federation. At the same time, studies conducted in foreign countries on the screening for CKD and some interventions aimed at slowing the progression of CKD suggest that in the Russian Federation, such approaches can be justified not only clinically, but also economically. It is necessary to conduct domestic research on the clinical and economic feasibility of interventions aimed at identifying and treating CKD at an early stage.
format Article
id doaj-art-84b4d7a6f82344bc8dab8fe0912231e4
institution DOAJ
issn 2070-4909
2070-4933
language Russian
publishDate 2021-10-01
publisher IRBIS LLC
record_format Article
series Фармакоэкономика
spelling doaj-art-84b4d7a6f82344bc8dab8fe0912231e42025-08-20T02:53:31ZrusIRBIS LLCФармакоэкономика2070-49092070-49332021-10-0114336537810.17749/2070-4909/farmakoekonomika.2021.100359An economic evaluation of pre-dialysis stage of chronic kidney diseaseE. I. Rumiantseva0M. V. Avxentyeva1Sechenov UniversitySechenov UniversityObjective: to review clinical and economic studies on the pre-dialysis stage of chronic kidney disease (CKD) and the cost-effectiveness of medical interventions used to detect CKD and prevent its progression.Material and methods. Articles were collected from the bibliographic databases PubMed, Cochrane Library and eLibrary for 2010–2020. Keywords for the search: ‘chronic kidney disease (CKD)’, ‘cost-effectiveness’, ‘economic evaluation’, ‘economic burden’, ‘cost’, ‘healthcare’. After the selection and elimination of the repeated articles, we reviewed 36 Russian and foreign studies on the economic burden of CKD and the clinical and economic effectiveness of various medical interventions of the CKD pre-dialysis stage.Results. We found 21 studies on the economic burden of CKD. A significant part of them (n=6) was performed in the United States.The methodology for assessing the economic burden varied significantly from study to study. Studies on medical interventions at the CKD predialysis stage can be divided into three groups: Group 1 (n=9) – studies on the clinical and economic effectiveness of screening programs; Group 2 (n=3) – studies on the clinical and economic effectiveness of nephroprotectors and other drugs that slow down the course of CKD; and Group 3 (n=3) – studies on the clinical and economic effectiveness of multidisciplinary care. We concluded on the clinical and economic feasibility of most interventions that were used to detect CKD and prevent its progression.Conclusion. We did not find any scientific data that could currently serve as a justification for the clinical and economic feasibility of CKD control programs in the Russian Federation. At the same time, studies conducted in foreign countries on the screening for CKD and some interventions aimed at slowing the progression of CKD suggest that in the Russian Federation, such approaches can be justified not only clinically, but also economically. It is necessary to conduct domestic research on the clinical and economic feasibility of interventions aimed at identifying and treating CKD at an early stage.https://www.pharmacoeconomics.ru/jour/article/view/551chronic kidney diseasecost-effectiveness analysiseconomic burdeneconomic evaluationpre-dialysis stage of chronic kidney disease
spellingShingle E. I. Rumiantseva
M. V. Avxentyeva
An economic evaluation of pre-dialysis stage of chronic kidney disease
Фармакоэкономика
chronic kidney disease
cost-effectiveness analysis
economic burden
economic evaluation
pre-dialysis stage of chronic kidney disease
title An economic evaluation of pre-dialysis stage of chronic kidney disease
title_full An economic evaluation of pre-dialysis stage of chronic kidney disease
title_fullStr An economic evaluation of pre-dialysis stage of chronic kidney disease
title_full_unstemmed An economic evaluation of pre-dialysis stage of chronic kidney disease
title_short An economic evaluation of pre-dialysis stage of chronic kidney disease
title_sort economic evaluation of pre dialysis stage of chronic kidney disease
topic chronic kidney disease
cost-effectiveness analysis
economic burden
economic evaluation
pre-dialysis stage of chronic kidney disease
url https://www.pharmacoeconomics.ru/jour/article/view/551
work_keys_str_mv AT eirumiantseva aneconomicevaluationofpredialysisstageofchronickidneydisease
AT mvavxentyeva aneconomicevaluationofpredialysisstageofchronickidneydisease
AT eirumiantseva economicevaluationofpredialysisstageofchronickidneydisease
AT mvavxentyeva economicevaluationofpredialysisstageofchronickidneydisease